mi rna data analysis 2013
DESCRIPTION
TRANSCRIPT
Sample & Assay Technologies
Data Analysis for the miScript miRNA PCR Arrays
Samuel J. Rulli, Ph.D.miRNA / qPCR Applications [email protected]
The miRNA PCR Arrays and reagents are intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of disease.
Sample & Assay Technologies
Data Analysis for the miScript miRNA PCR Arrays
The miRNA PCR Arrays and reagents are intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of disease.
Questions, Comments, Concerns?US Applications Support
Questions, Comments, Concerns?Global Applications Support
Sample & Assay Technologies- 3 -
Overview of Webinar
.I. Brief Technology and Protocol Overview� What a miRNA PCR Array looks like� Simple Protocol
.II. Calculating Fold change Values � Baseline and Threshold settings� Exporting and Organizing Data� Experimental Design
� Basic Experiment with HKGs� Website Demonstration
� Basic Experiment with No HKGs? What do I use?� Serum miRNA Applications
� Summary� Pilot Study Promotion/ Re-Order Promotion
The miRNA PCR Arrays and reagents is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of disease.
Sample & Assay Technologies- 4 -
Anatomy of a catalogued miRNA PCR Array
.84 Pathway-Specific miRNAs
.miRNA isolation control n=2
.6 “Housekeeping”
.snRNAs
.miRNA Reverse Transcription Controls (miRTC) n=2
.Positive PCR Controls (PPC) n=2
PPCMi-
RTCPPC
Mi-RTC
RNU6-2
SNORD96A
SNORD95
SNORD72
miR-142-5p
miR-16
miR-142-3p
miR-21
miR-15a
miR-29b
Let-7a
miR-126
miR-143
miR-27a
miR-9
miR-26a
Let-7b
Let-7f
miR-24
miR-30e
miR-181a
miR-29a
miR-124
miR-144
miR-30d
miR-19b
miR-22
miR-122
miR-150
miR-32
miR-155
miR-140-5p
miR-125b
miR-141
miR-92a
miR-424
miR-191
miR-17
miR-130a
miR-20a
miR-27b
miR-26b
miR-146a
miR-200c
miR-99a
miR-19a
miR-23a
miR-30a
Let-7i
miR-93
miR-106b
Let-7c
miR-101
Let-7g
miR-425
miR-15b
miR-28-5p
miR-18a
miR-25
miR-23b
miR-302a
miR-186
miR-29c
miR-7
Let-7d
miR-30c
miR-181b
miR-223
miR-320
miR-374a
miR-151-5p
Let-7e
miR-374b
miR-196b
miR-140-3p
miR-100
miR-103
miR-96
miR-302b
miR-194
miR-125a-5p
miR-423-5p
miR-376c
miR-195
miR-222
miR-28-3p
miR-128a
miR-302c
miScript miRNA PCR Array Human miFinder (MIHS-001Z)
Cel-miR-39
Cel-miR-39
SNORD61
SNORD68
The miRNA PCR Arrays and reagents are intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of disease.
Sample & Assay Technologies- 5 -
How miScript miRNA PCR Arrays Work
cDNA Synthesis � universal RT Reaction� 1 hours
Load Plates � 2 minutes
Export Raw Ct Values
Biologically Relevant Fold Change Values∆∆ Ct calculations
“mir-103 is up-regulated 5 fold in experiment versus control”
Sample & Assay Technologies- 6 -
cDNA Synthesis � universal RT Reaction� 1 hours
Load Plates � 2 minutes
Export Raw Ct Values
Biologically Relevant Fold Change Values∆∆ Ct calculations
“mir-103 is up-regulated 5 fold in experiment versus control”
How miScript miRNA PCR Arrays Work
Sample & Assay Technologies- 7 -
Overview of Webinar
.I. Brief Technology and Protocol Overview� What a miRNA PCR Array looks like� Simple Protocol
.II. Calculating Fold change Values� Baseline and Threshold settings� Exporting and Organizing Data� Experimental Design
� Basic Experiment with HKGs� Website Demonstration
� Basic Experiment with No HKGs? What do I use?� Summary
Sample & Assay Technologies- 8 -
.Baseline • Use Automated Baseline
-(if your instrument has Adaptive Baseline function) OR• Manually Set Baseline
-Using Linear View:Set to Cycle #2 or #3 up to 1 or 2 cycle values before earliest amplification (with highest cycle being cycle #15)
.Threshold Value • Use Log View• Place in
1) Linear phase of amplification curve2) Above background signal, but within lower half to one third of curve
.Export Ct values to blank spread sheet (Excel).
.Threshold Must Be Same Between Runs (important for PPC and RTC andselecting house keeping genes) )
For ABI, Stratagene, Bio-Rad, and Eppendorf Real-Ti me PCR Instruments*:
*For Roche LC480: Use Second Derivative Maximum
Defining Baseline and Threshold
Sample & Assay Technologies- 9 -
.Baseline • Use Automated Baseline
-(if your instrument has Adaptive Baseline function) OR• Manually Set Baseline
-Using Linear View:Set to Cycle #2 or #3 up to 1 or 2 cycle values before earliest amplification (with highest cycle being cycle #15)
.Threshold Value • Use Log View• Place in
1) Linear phase of amplification curve2) Above background signal, but within lower half to one third of curve
.Export Ct values to blank spread sheet (Excel).
.Threshold Must Be Same Between Runs (important for PPC and RTC andselecting house keeping genes) )
For ABI, Stratagene, Bio-Rad, and Eppendorf Real-Ti me PCR Instruments*:
*For Roche LC480: Use Second Derivative Maximum
Defining Baseline and Threshold
Sample & Assay Technologies- 10 -
.Baseline • Use Automated Baseline
-(if your instrument has Adaptive Baseline function) OR• Manually Set Baseline
-Using Linear View:Set to Cycle #2 or #3 up to 1 or 2 cycle values before earliest amplification (with highest cycle being cycle #15)
.Threshold Value • Use Log View• Place in
1) Linear phase of amplification curve2) Above background signal, but within lower half to one third of curve
.Export Ct values to blank spread sheet (Excel).
.Threshold Must Be Same Between Runs (important for PPC and RTC andselecting house keeping genes) )
For ABI, Stratagene, Bio-Rad, and Eppendorf Real-Ti me PCR Instruments*:
*For Roche LC480: Use Second Derivative Maximum
Defining Baseline and Threshold
Sample & Assay Technologies- 11 -
.Baseline • Use Automated Baseline
-(if your instrument has Adaptive Baseline function) OR• Manually Set Baseline
-Using Linear View:Set to Cycle #2 or #3 up to 1 or 2 cycle values before earliest amplification (with highest cycle being cycle #15)
.Threshold Value • Use Log View• Place in
1) Linear phase of amplification curve2) Above background signal, but within lower half to one third of curve
.Export Ct values to blank spread sheet (Excel).
.Threshold Must Be Same Between Runs (important for PPC and RTC andselecting house keeping genes) )
For ABI, Stratagene, Bio-Rad, and Eppendorf Real-Ti me PCR Instruments*:
*For Roche LC480: Use Second Derivative Maximum
Defining Baseline and Threshold
Sample & Assay Technologies- 12 -
.Baseline • Use Automated Baseline
-(if your instrument has Adaptive Baseline function) OR• Manually Set Baseline
-Using Linear View:Set to Cycle #2 or #3 up to 1 or 2 cycle values before earliest amplification (with highest cycle being cycle #15)
.Threshold Value • Use Log View• Place in
1) Linear phase of amplification curve2) Above background signal, but within lower half to one third of curve
.Export Ct values to blank spread sheet (Excel).
Threshold Must Be Same Between Runs (important for PPC and RTC and selecting house keeping genes)
For ABI, Stratagene, Bio-Rad, and Eppendorf Real-Ti me PCR Instruments*:
*For Roche LC480: Use Second Derivative Maximum
Defining Baseline and Threshold
Sample & Assay Technologies- 13 -
.Baseline • Use Automated Baseline
-(if your instrument has Adaptive Baseline function) OR• Manually Set Baseline
-Using Linear View:Set to Cycle #2 or #3 up to 1 or 2 cycle values before earliest amplification (with highest cycle being cycle #15)
.Threshold Value • Use Log View• Place in
1) Linear phase of amplification curve2) Above background signal, but within lower half to one third of curve
.Export Cp values to blank spread sheet (Excel).
Threshold Must Be Same Between Runs (important for PPC and RTC and selecting house keeping genes)
*For Roche LC480: Use Second Derivative Maximum
Defining Baseline and Threshold
Sample & Assay Technologies- 14 -
Linear View
Setting Baseline
Sample & Assay Technologies- 15 -
Linear View
Select “AUTO CALCULATED”
Setting Baseline
Sample & Assay Technologies- 16 -
Log View
Setting Threshold
Sample & Assay Technologies- 17 -
Threshold Line
Setting Threshold
Sample & Assay Technologies- 18 -
Threshold Line
C(t)
Setting Threshold
Sample & Assay Technologies- 19 -
Threshold Line
C(t)
Setting Threshold
Use the Same Threshold for All PCR Arrays
Sample & Assay Technologies- 20 -
2 Ways to “CRUNCH” the Data
Excel Based Templates
•Free!•Download from http://www.sabiosciences.com/mirnaArrayDataAnalysis.php•Good for 2 Group Comparisons (Control + Experimental)•10 PCR Arrays per Group
Web-Based Data Analysis
•Free!•Upload Excel spreadsheet at
•http://pcrdataanalysis.sabiosciences.com/mirna/arrayanalysis.php•Good for 11 Group Comparisons (Control + 10 Experimental)•255PCR Arrays Total
Sample & Assay Technologies- 21 -
Excel Based Templates
•Free!•Download from http://www.sabiosciences.com/mirnaArrayDataAnalysis.php•Good for 2 Group Comparisons (Control + Experimental)•10 PCR Arrays per Group
Web-Based Data Analysis
•Free!•Upload Excel spreadsheet at http://www.sabiosciences.com/pcr/arrayanalysis.php•Good for 11 Group Comparisons (Control + 10 Experimental)•255PCR Arrays Total
2 Ways to “CRUNCH” the Data
Sample & Assay Technologies- 22 -
Excel Based Templates
•Free!•Download from http://www.sabiosciences.com/mirnaArrayDataAnalysis.php•Good for 2 Group Comparisons (Control + Experimental)•10 PCR Arrays per Group
Web-Based Data Analysis
•Free!•Upload Excel spreadsheet athttp://pcrdataanalysis.sabiosciences.com/mirna/arrayanalysis.php•Good for 11 Group Comparisons (Control + 10 Experimental)•255PCR Arrays Total
2 Ways to “CRUNCH” the Data
Sample & Assay Technologies- 23 -
Organizing Raw C(t) values
Download Excel Template from SABiosciences’ Web Portal…or make your own.
Cataloged Array
Row 1Sample Name
Column A:Well Location
Column B-??:
Raw C(t) Values
Sample & Assay Technologies- 24 -
Download Excel Template from SABiosciences’ Web Portal…or make your own.
Cataloged Array
Row 1Sample Name
Column A:Well Location
Column B-??:
Raw C(t) Values
Organizing Raw C(t) values
Sample & Assay Technologies- 25 -
Download Excel Template from SABiosciences’ Web Portal…or make your own.
Cataloged Array
Row 1Sample Name
Column A:Well Location
Column B-??:
Raw C(t) Values
Organizing Raw C(t) values
Sample & Assay Technologies- 26 -
Download Excel Template from SABiosciences’ Web Portal…or make your own.
Cataloged Array
Row 1Sample Name
Column A:Well Location
Column B-??:
Raw C(t) Values
Organizing Raw C(t) values
Sample & Assay Technologies- 27 -
Experiment miRNA expression Profiling during differ entiation
hMSC
Osteogenesis – Day 16
Neurogenesis – 72 hr
T1T2
T3T4
T1T2
T3T4
Differentiation protocolCollect miRNA at different time pointsRepeat experiment 3x (biological replicates)
Sample & Assay Technologies- 28 -
Experiment miRNA expression Profiling during differ entiation
hMSC
Osteogenesis – Day 16
T1T2
T3T4
Differentiation protocolCollect miRNA at different time pointsRepeat experiment 3x (biological replicates)
Sample & Assay Technologies- 29 -
Our Experiment-Data Analysis Overview
A A A A
Control Group 1 Group 2 Group 3
B CB CB CCB
3 biological replicates that will be grouped into (3 groups + control)
hMSCs Time Point 1 Time Point 2 Time Point 3
Sample & Assay Technologies- 30 -
A B C A B C A B C A B C
1 PCR Array for Each Sample
A A A A
Control Group 1 Group 2 Group 3
B CB CB CCB
Our Experiment-Data Analysis Overview
Sample & Assay Technologies- 31 -
C(t)GOI- C(t)HKG
∆C(t)
1. Calculate ∆∆∆∆ C(t) for on each array for each GOI (Gene Of Interest)
A B C A B C A B C A B C
A A A A
Control Group 1 Group 2 Group 3
B CB CB CCB
Our Experiment-Data Analysis Overview
Sample & Assay Technologies- 32 -
∆C(t)+∆C(t)+∆C(t)
3∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
1. Calculate ∆ C(t) for on each array for each GOI (Gene Of Interest)2. Calculate Average ∆∆∆∆ C(t) for each gene within a Group
∆C(t)∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t)
A B C A B C A B C A B C
A A A A
Control Group 1 Group 2 Group 3
B CB CB CCB
Our Experiment-Data Analysis Overview
Sample & Assay Technologies- 33 -
1. Calculate ∆∆∆∆ C(t) for on each array for each GOI (Gene Of Interest)2. Calculate Average ∆∆∆∆ C(t) for each gene within a Group3. Calculate ∆∆∆∆∆∆∆∆ C(t) for each gene between Groups
∆C(t)∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t)
A B C A B C A B C A B C
Control Group 1 Group 2 Group 3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
Our Experiment-Data Analysis Overview
Sample & Assay Technologies- 34 -
1. Calculate ∆∆∆∆ C(t) for on each array for each GOI (Gene Of Interest)2. Calculate Average ∆∆∆∆ C(t) for each gene within a Group3. Calculate ∆∆∆∆∆∆∆∆ C(t) for each gene between Groups4. Calculate Fold Change: 2(-∆∆∆∆∆∆∆∆Ct)
∆C(t)∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t) ∆C(t)
A B C A B C A B C A B C
Control Group 1 Group 2 Group 3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
∆C(t)+∆C(t)+∆C(t)
3
Our Experiment-Data Analysis Overview
Sample & Assay Technologies- 35 -
On-Line Data Analysis Demonstration
Sample & Assay Technologies- 36 -
What are HKGs? Why do I need them? (Do I need them ?)
.House-keeping genes or Normalization genes:� Expressed in all samples and co-purify with miRNA fraction� Not changing expression levels due to disease or experimental conditions� Used to normalize for amount of sample and RT efficiency� 6 small non-coding RNAs included on each array as “HKGs”
� Ex: SNORD 61, SNORD 68, SNORD 72 , SNORD 95 , SNORD 96A, RNU6-2� Any other miRNA or assay on the miRNA Array can be a normalization gene
� Use 1 HKG or an average of the most stable HKGs
� Identification of stable HKGs� Prior experience / data from publication� Start with same amount of sample (RNA) and assume equal RT efficiency (actually
can measure this with miRNA RTC)� Pair-wise comparison (delta- Ct) between genes and assume genes are not changing
expression levels in the same direction.
Sample & Assay Technologies- 37 -
Special Cases: Alternative ways to find HKGs
� Pair wise Comparison:
Ct (HKG1) 22 23 26
Ct (HKG2) 18 19 22
Delta Ct 4 4 4
Useful if:starting with different amounts of sampleusing different threshold setting on machine or different machineshave different RT efficiencies
Sample & Assay Technologies- 38 -
Special Cases: Serum Analysis or No HKGs
Isolation of miRNAs from Serum creates problems in normalizationNo universal endogenous HKGs
What is a good normalization strategy?�None (normalize to volume)�snRNA or miRNA in samples �All (global normalization)�spike in control
Sample & Assay Technologies- 39 -
.84 Pathway-Specific miRNAs
.miRNA isolation control n=2
.6 “Housekeeping”
.snRNAs
.miRNA Reverse Transcription Controls (miRTC) n=2
.Positive PCR Controls (PPC) n=2
PPCMi-
RTCPPC
Mi-RTC
RNU6-2
SNORD96A
SNORD95
SNORD72
miR-142-5p
miR-16
miR-142-3p
miR-21
miR-15a
miR-29b
Let-7a
miR-126
miR-143
miR-27a
miR-9
miR-26a
Let-7b
Let-7f
miR-24
miR-30e
miR-181a
miR-29a
miR-124
miR-144
miR-30d
miR-19b
miR-22
miR-122
miR-150
miR-32
miR-155
miR-140-5p
miR-125b
miR-141
miR-92a
miR-424
miR-191
miR-17
miR-130a
miR-20a
miR-27b
miR-26b
miR-146a
miR-200c
miR-99a
miR-19a
miR-23a
miR-30a
Let-7i
miR-93
miR-106b
Let-7c
miR-101
Let-7g
miR-425
miR-15b
miR-28-5p
miR-18a
miR-25
miR-23b
miR-302a
miR-186
miR-29c
miR-7
Let-7d
miR-30c
miR-181b
miR-223
miR-320
miR-374a
miR-151-5p
Let-7e
miR-374b
miR-196b
miR-140-3p
miR-100
miR-103
miR-96
miR-302b
miR-194
miR-125a-5p
miR-423-5p
miR-376c
miR-195
miR-222
miR-28-3p
miR-128a
miR-302c
miScript miRNA PCR Array Human Serum and Plasma (MI HS-106Z)
Cel-miR-39
Cel-miR-39
SNORD61
SNORD68
Anatomy of a Serum miRNA PCR Array
The miRNA PCR Arrays and reagents are intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of disease.
Sample & Assay Technologies- 40 -
Serum miRNA Profiling
.Human Serum miScript miRNA PCR Array (MIHS-106Z)� Profile the expression of mature miRNA sequences that researchers have
detected in serum and other bodily fluids� Includes miRNAs found to be present at higher levels in serum from
individuals with specific diseases� Heart and liver injury or disease, atherosclerosis, diabetes, and a number of
organ-specific cancers
� What is on the array?� 84 mature miRNA sequences� miRNA housekeeping gene assays� Reverse Transcription Control assays� PCR Control assays� RNA Recovery Control assays
– Works with separately purchased Syn-cel-miR-39 miScript miRNA Mimic (MSY0000010) spiked into the sample before nucleic acid preparation to monitor biological fluid miRNA recovery rates
The miRNA PCR Arrays and reagents is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of disease.
Sample & Assay Technologies- 41 -
Expression Profiling of Normal Human Serum Samples
.Two “normal” human serum samples (Sample A and Sample B)� Total RNA was isolated using the miRNeasy Mini Kit
� QIAGEN Supplementary Protocol for total RNA purification from serum or plasma� Optional syn-cel-miR-39 spike-in control included
� 5 µl of each RNA elution was used in an miScript miRNA First Strand Kit reverse transcription reaction
� Mature miRNA expression was profiled using the Human Serum miScript miRNA PCR Array (MIHS-106Z)
15
20
25
30
35
40
15 20 25 30 35 40
Raw Ct: Serum Sample A
Raw
Ct:
Ser
um S
ampl
e B
R2 = 0.9079
� Non-normalized Ct values are highly comparable� How should the data be normalized to uncover fine
differences between the two samples?
Sample & Assay Technologies- 42 -
Expression Profiling of Normal Human Serum Samples
.Two normal human serum samples (Sample A and Sample B)� Total RNA was isolated using the miRNeasy Mini Kit
� QIAGEN Supplementary Protocol for total RNA purification from serum or plasma� Option syn-cel-miR-39 spike-in control included
� 5 µl of each RNA elution was used in an miScript miRNA First Strand Kit reverse transcription reaction
� Mature miRNA expression was profiled using the Human Serum miScript miRNA PCR Array (MAH-106)
15
20
25
30
35
40
15 20 25 30 35 40
Raw Ct: Serum Sample A
Raw
Ct:
Ser
um S
ampl
e B
R2 = 0.9079
� Non-normalized Ct values are highly comparable� How should the data be normalized to uncover fine
differences between the two samples?
15
20
25
30
35
40
15 20 25 30 35 40
Raw Ct: Serum Sample A
Raw
Ct: Ser
um S
ample
B
R2 = 0.9079
Sample & Assay Technologies- 43 -
Expression Profiling of Normal Human Serum Samples
.Two normal human serum samples (Sample A and Sample B)� Total RNA was isolated using the miRNeasy Mini Kit
� QIAGEN Supplementary Protocol for total RNA purification from serum or plasma� Option syn-cel-miR-39 spike-in control included
� 5 µl of each RNA elution was used in an miScript miRNA First Strand Kit reverse transcription reaction
� Mature miRNA expression was profiled using the Human Serum miScript miRNA PCR Array (MAH-106)
15
20
25
30
35
40
15 20 25 30 35 40
Raw Ct: Serum Sample A
Raw
Ct:
Ser
um S
ampl
e B
R2 = 0.9079
� Non-normalized Ct values are highly comparable� How should the data be normalized to uncover fine
differences between the two samples?
15
20
25
30
35
40
15 20 25 30 35 40
Raw Ct: Serum Sample A
Raw
Ct: Ser
um S
ample
B
R2 = 0.9079
RAW Ct or volume normalization assumes:Same isolation efficiencySame RT efficiencySame baseline and threshold settingsSame volumetric constraints
Sample & Assay Technologies- 44 -
Serum Sample Data Normalization
.Step 1: Check reverse transcription control (miRTC) and PCR control (PPC) Ct values
Position Control Ct: Sample A Ct: Sample B
H09 miRTC 18.76 18.52
H10 miRTC 18.73 18.64
H11 PPC 19.43 19.61
H12 PPC 19.61 19.76
� As determined by the raw Ct values, the reverse transcription and PCR efficiency of both samples are highly comparable
� Ct values differ by less than 0.25 units
Sample & Assay Technologies- 45 -
Serum Sample Data Normalization (cont.)
.Step 2: Observe housekeeping gene Ct values
Position GeneCt: Sample
A Ct: Sample B
H05 SNORD72 31.81 32.79
H06 SNORD95 35.00 35.00
H07 SNORD96A 35.00 35.00
H08 RNU6-2 35.00 35.00
� Housekeeping genes are either not expressed or exhibit borderline detectable expression
� As is often found with serum samples, standard housekeeping genes cannot be used for data normalization
� How should you proceed?
Sample & Assay Technologies- 46 -
Serum Sample Data Normalization (cont.)
� Four potential data normalization options
1. Normalize data of each plate to its RNA Recovery Control Assays (wells H02 to H04)� Can only be used if Syn-cel-miR-39 miScript miRNA Mimic
(MSY0000010) was spiked into the sample before nucleic acid preparation
2. Normalize data to Ct mean of all expressed targets (targets with Ct < 35) for a given plate
3. Normalize data to Ct mean of targets that are commonly expressed in the two samples of interest
4. Normalize data to ‘0’� Essentially you are relying on the consistency in the quantity and
quality of your original RT input
Sample & Assay Technologies- 47 -
Serum Sample Data Normalization (cont.)Option 1: Normalize to RNA Recover Control Assays
� Calculate the average Ct of the cel-miR-39 wells (H02 to H04)
� Sample A: 17.85� Sample B: 19.42
� Using these cel-miR-39 Ct means as normalizers, calculate ∆∆Ct values, fold-change, and fold up/down regulation
Position Control Ct: Sample A Ct: Sample B
H02 cel-miR-39 17.84 19.37
H03 cel-miR-39 17.85 19.49
H04 cel-miR-39 17.85 19.39
-40
-20
0
20
40
60
80
100
Fol
d-R
egul
atio
n (B
to A
)
Sample & Assay Technologies- 48 -
Serum Sample Data Normalization (cont.)Option 2: Normalize to Ct Mean of All Expressed Targets for a given plate
� Determined the number of expressed targets in each plate (Ct < 35)� Sample A: 66� Sample B: 59
� Calculate the Ct Mean of the expressed targets� Sample A: 28.96� Sample B: 29.70
� Using these Ct means as normalizers, calculate ∆∆Ct values, fold-change, and fold up/down regulation
� NOTE: same strongly up-regulated and down-regulated miRNAs are identified
-60
-40
-20
0
20
40
60
Fol
d-R
egul
atio
n (B
to A
)
Sample & Assay Technologies- 49 -
Serum Sample Data Normalization (cont.)Option 3: Normalize to Ct Mean of Commonly Expressed Targets
� Determined the number of commonly expressed targets for the plates being analyzed (Ct < 35 in all samples)
� Commonly expressed in Sample A and Sample B: 48
� Calculate the associated Ct Mean� Sample A: 27.52� Sample B: 28.86
� Using these Ct means as normalizers, calculate ∆∆Ct values, fold-change, and fold up/down regulation
� NOTE: same strongly up-regulated and down-regulated miRNAs are identified
-40
-20
0
20
40
60
80
Fol
d-R
egul
atio
n (B
to A
)
Sample & Assay Technologies- 50 -
Serum Sample Data Normalization (cont.)Option 4: Normalize to ‘0’
� Normalizing to ‘0’ relies on the consistency in the quantity and quality of your original RT input
� For serum samples, this may not be the best option, as the RNA is not routinely quantified prior to addition to a reverse transcription reaction
� Normalizing the data to ‘0’, calculate ∆∆Ct values, fold-change, and fold up/down regulation
� NOTE: These results are not completely comparable to the results achieved with the other three normalization methods. The same strongly up-regulated and down-regulated miRNAs are identified; however, additionally up- and down-regulated genes are potentially (incorrectly) identified. This suggests that there is the need for some method of normalization, other than just normalizing to ‘0’.
-100
-80
-60
-40
-20
0
20
40
Fol
d-R
egul
atio
n (B
to A
)
Sample & Assay Technologies- 51 -
miRNA Data Analysis Summary
When setting baseline and theshold with your qPCR I nstrument:ABI, Stratagene, BioRad, Eppendorf•Automatic Baseline•Threshold in lower ½ to lower 1/3 of curves (PPC = 18 to 22)Roche LC480:•Second derivative maximum
Export and Collect Raw Ct values. Organize for uploa d
Organize experiment: Group Biological/Technical replicates
Focus on Sample and Experimental QualityRTCs; PPCs; Spike in Control (if applicable)
Select MOST STABLE HKGs for your experiment
Click through Fold Change Data, Export Results, Pub lish